muscle
• significantly reduced ejection fraction at 2 years of age
• decreased myocardial contractility (dP/dtmax value) at 1 year of age
|
• pathological alterations consistent with cardiomyopathy
|
• typical signs of dilated cardiomyopathy with significantly lower stroke volumes and ejection fractions in conjunction with increased end-systolic and end-diastolic volumes at 2 years of age
|
• massive subsarcolemmal protein aggregate pathology, autophagic vacuoles, Z-band streaming, and lysis of myofibrils in soleus muscle at 6 months of age
|
• marked Z-band streaming in soleus muscle at 6 months of age
|
• step-wise fiber stretching analysis revealed that chemically skinned small fiber bundles isolated from 4.5-mo-old soleus muscles show markedly higher biomechanical stiffness, i.e., increased restoration force at identical extensions, than wild-type controls, indicating reduced fiber elasticity
• 4 of 5 fibers display passive-stretch-induced ruptures, unlike wild-type fibers
|
• mitochondrial pathology involving multiple skeletal muscle fibers, with focal changes of cytochrome C oxidase and succinate dehydrogenase enzyme activities in soleus muscle at 3 months of age
• focal accumulation or depletion of mitochondria as well as giant mitochondria in soleus muscle at 16 months of age, as shown by COX staining
|
• age-related increase in pathological fiber size variations in soleus muscle
|
• age-related increase in centralized myonuclei in soleus muscle
|
• moderate degenerative changes in soleus muscle at 3 months of age, with signs of myofibril degeneration at 6 months of age
|
• age-related increase in fiber degeneration in soleus muscle, with signs of myofibril lysis at 6 months of age
|
• age-related increase in endomysial connective tissue in soleus muscle
|
• age-related progression of dystrophic changes in soleus muscle, evident at 16 months of age
|
• significantly reduced force development in explanted soleus muscles subjected to twitch and tetanic force recordings relative to wild-type controls
|
• progressive skeletal muscle weakness
|
• progressive skeletal muscle myopathy with an age-related increase in the extent of degenerative changes in soleus muscle tissue, including increased endomysial connective tissue, rounding of muscle fibers, pathological fiber size variations, centralization of myonuclei, and degenerating muscle fibers
• similar myopathic changes are detected in the diaphragm but not in gastrocnemius or quadriceps femoris muscles
|
behavior/neurological
• significant reduction in the 4-paw grip strength at 19 months of age relative to wild-type controls
• severely poor performance in the wire hanging test
|
cardiovascular system
• increased connective tissue in cardiac muscle at 3 months of age, more prominent than in heterozygotes
|
• significantly reduced cardiac stroke volume at 2 years of age
|
• significantly reduced ejection fraction at 2 years of age
• decreased myocardial contractility (dP/dtmax value) at 1 year of age
|
• increased numbers of episodes with ventricular tachycardias (VTs)
• ventricular stimulations lead to a significant increase in the number of VT episodes
|
• arrhythmias
|
• increased numbers of episodes with atrial fibrillation
• long-lasting (>1 min) AF-episodes
|
• significantly increased number of polymorphic premature ventricular contractions (PVCs) during physical stress (10 min swimming exercise) at 6 months of age
|
• conduction defects
|
• higher grade AV blocks under conditions of stress
• 2nd and 3rd degree AV blocks, never observed in wild-type controls
|
• long-term telemetric baseline electrocardiography recordings revealed atrial and ventricular extrasystoles at 6 months of age
|
• significantly prolonged HV intervals
• however, supra-Hisian AV nodal conductance (AH interval) is normal
|
• higher grade sino-atrial blocks under conditions of stress
|
• pathological alterations consistent with cardiomyopathy
|
• typical signs of dilated cardiomyopathy with significantly lower stroke volumes and ejection fractions in conjunction with increased end-systolic and end-diastolic volumes at 2 years of age
|
cellular
• mitochondrial pathology involving multiple skeletal muscle fibers, with focal changes of cytochrome C oxidase and succinate dehydrogenase enzyme activities in soleus muscle at 3 months of age
• focal accumulation or depletion of mitochondria as well as giant mitochondria in soleus muscle at 16 months of age, as shown by COX staining
|
• giant mitochondria in soleus muscle at 16 months of age
|
limbs/digits/tail
• massive subsarcolemmal protein aggregate pathology, autophagic vacuoles, Z-band streaming, and lysis of myofibrils in soleus muscle at 6 months of age
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
myofibrillar myopathy 1 | DOID:0080092 |
OMIM:601419 |
J:219616 |